M1A.172
Lead-induced chronic gout, left ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Lead-induced chronic gout is a form of gout caused by prolonged exposure to lead, which leads to the accumulation of uric acid crystals in joints, resulting in chronic joint inflammation. This specific condition affects the left ankle and foot, leading to recurrent pain and swelling. Recognized under ICD-10 code M1A.172, this condition is a rare but serious consequence of lead poisoning that requires medical attention for management and prevention.
Causes & Symptoms
Clinical Causes: Prolonged exposure to lead through occupational hazards, such as working in industries involving lead smelting, battery manufacturing, or construction work with lead-based materials. Environmental exposure, including contaminated water, soil, or dust that contains lead particles. Improper handling or ingestion of lead-contaminated substances. Chronic lead poisoning leading to impaired excretion of uric acid, causing accumulation and crystal formation in joints.
Key Symptoms: Persistent pain and swelling in the left ankle and foot. Recurrent episodes of joint redness and warmth. Limited range of motion in the affected joints. Presence of tophi, which are deposits of uric acid crystals under the skin. In severe cases, joint deformity and chronic arthritis. Possible signs of lead poisoning such as fatigue, abdominal pain, and cognitive changes.
Diagnostic & Treatment
Diagnosis Path: Blood tests to measure blood lead levels, confirming lead poisoning. Serum uric acid tests to assess hyperuricemia. X-ray imaging of the affected joints to detect joint damage and uric acid crystal deposits. Synovial fluid analysis from affected joints to identify uric acid crystals under a microscope. Assessment of occupational and environmental history to identify lead exposure sources.
Treatment Protocols: Chelation therapy to reduce lead levels in the body, using agents such as dimercaprol or EDTA, under medical supervision. Medications to control gout symptoms, including nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids during acute attacks. Urate-lowering therapies, such as allopurinol or febuxostat, to prevent uric acid crystal formation. Lifestyle modifications, including dietary changes to reduce purine intake and alcohol consumption. Avoidance of further lead exposure by improving workplace safety measures and environmental hygiene. Regular monitoring of blood lead and uric acid levels to evaluate treatment effectiveness.
Clinical Advice & FAQs
Billing Guidance
Is M1A.172 a billable ICD-10 code?
Yes, M1A.172 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.172?
Clinical documentation must specify the nature of Lead-induced chronic gout, left ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference